BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers
Human Pathology Nov 12, 2017
Wang GH, et al. - Protein expression of BRCA1 and BRCA2 in 4 digestive system cancers (gastric cancer, colorectal cancer, hepatocellular carcinoma, and pancreatic cancer) was determined by immunohistochemistry (IHC) on tissue microarrays. To assess the prognosis of digestive system cancers, BRCA1 and BRCA2 can be used as clinicopathological biomarkers.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
